Key statistics dashboard for Coeptis Therapeutics Holdings, Inc. (COEP). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology.
Stock Data
| Price | $10.99 |
| Market Cap | $39M |
| Enterprise Value | $23.1M |
| Beta | -0.43 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -6.11 |
| Price / Book | 4.13 |
| P/S | 13.81 |
| EV/EBITDA | -1.12 |
| EV/Sales | 8.27 |
| EV/FCF | -5.72 |
| P/FCF | -9.55 |
| Earnings Yield | -4.03% |
| FCF Yield | -10.47% |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 16.78% |
| EBIT Margin | -277.97% |
| EBITDA Margin | -740.40% |
| Operating Margin | -792.87% |
| Net Margin | -788.80% |
| Return on Equity | -48.21% |
| Return on Assets | -16.40% |
| Return on Invested Capital | -16.68% |
| Return on Capital Employed | -16.74% |
Financial Health
| Current Ratio | 7.66 |
| Quick Ratio | 7.66 |
| Cash Ratio | 7.64 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Net Debt / EBITDA | 0.75 |
| Interest Coverage | -43.64 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 7.84 |
Per-Share Data
| Revenue per share | 0.06 |
| Book Value per share | 2.66 |
| Cash per share | 0.31 |
| FCF per share | -0.08 |
| Tangible Book Value per share | 0.51 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: CUE · EQ · IPSC · KPTI · MDCX · NRXP · OSTX
Explore sector: Technology · Software - Services
More sections of COEP: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks